The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says ...

CHAMPAIGN — Compounding pharmacists don't just customize drugs for individual patients with special needs. As pharmaceutical companies have stopped making some products, compounding pharmacists have ...

The launch of the new website is part of Olympia's broader initiative to modernize its digital infrastructure and deepen its connections within the healthcare industry. This is a key step in the ...

Compounding pharmacies can offer a life-saving medicine to patients who may not be able to take standard medication, but the industry is in the midst of challenges because of rules and regulations ...

How Three-Entity Telehealth Platforms Handle Prescription Peptide Evaluation, Compounded Medication Dispensing, and Realistic ...

A new company financed by Bain Capital intends to stake a position in the sterile compounding market. QuVa Pharma has started by acquiring an FDA 503B registered compounding facility in Sugar Land, TX ...

ProRx's oral NAD+ is offered in a 1 mL daily-use ampule, compounded under strict USP <795> and cGMP standards in the company's FDA-registered 503B facility. Each batch undergoes third-party potency, ...

Equity Commitment from Bain Capital Private Equity; Experienced Management Team from JHP Pharmaceuticals — August 24, 2015 – QuVa Pharma, Inc., a newly formed national platform for sterile compounding ...

ORANGE, Calif., Aug. 28, 2025 /PRNewswire/ -- Has a new breed of "Pharma Bros" emerged to undermine legitimate providers and potentially put patient safety at risk? They're not hedge fund traders or ...

WEST LAFAYETTE, Ind., and INDIANAPOLIS – A Purdue-related startup is developing the first USP 797 certified, virtual pharmacy cleanroom laboratory for students and other industry professionals to gain ...